← Insider buys
PCRX

Pacira BioSciences, Inc. · Healthcare

SVP, Finance Lauren Bullaro Riker sold $71K of Pacira BioSciences, Inc.

Sold$70,580
$61.37Price
1,150Shares
−5%Stake

What PCRX did after the filing

Filed Jun 8Copier in Jun 9
The stock from Thu, Jun 9 open, $58.58
−2.7%
S&P 500, same days
−2.9%

Measured over 30 trading days, to the Jul 25 close.

Traded Mon, Jun 6. Filed Wed, Jun 8. Returns use the Jun 9 open and the Jul 25 close. Not investment advice.